The Silver Lining from COVID-19 for Clinical Trials
The Silver Lining from COVID-19 for Clinical Trials

Former Oracle Health Sciences general manager Steve Rosenberg talked about these changes as part of a discussion on clinical trial technology in a recent EDC Clinical Leader Live event. In working with so many companies who are using Oracle Clinical One for COVID-19 related studies, Rosenberg has seen the impact of COVID-19 on trials firsthand. In many cases, companies have stopped enrolling people in existing trials or delayed new trials because COVID-19 precludes a lot of in-person clinic visits.

More Ways to Read:
🧃 Juice It The key takeaways that can be read in under a minute
Sign up to unlock